ANNA AHLBERG NEW CFO AT VITROLIFE AB (publ)

Anna Ahlberg has been appointed as Head of Vitrolife's accounting and
financing department and for investor relations.

Anna Ahlberg has worked within the field of accounting and financing, as
well as with investor relations, since 1994, first at Monark Stiga AB, a
company at the time listed at the Stockholm Stock Exchange in Sweden,
and then at Q-Med AB. Q-Med is a medical device company where Anna
worked first as Financial Manager and then after the listing of the
company in 1999 as Director of Investor Relations. Anna's last position
has been as business controller at Caran, a company owned by WM-data AB,
a listed company providing IT-related services.

Anna will start at Vitrolife during the month of August.

Gothenburg, June 22, 2004.

Vitrolife AB (publ)

 For further information, please contact;
                           
 CEO: Dr. Magnus Nilsson   CFO and IR agent: Anna Ahlberg
 Tel: +46 31 721 80 00     Tel: +46 31 761 10 36
 Mobile +46 708 22 80 61   
 [email protected]    [email protected]

Vitrolife is a global biomedical corporation that works with products
for cell and tissue technology. The Vitrolife group consists of the
parent company, Vitrolife AB (Publ) and two wholly owned subsidiaries:
Vitrolife Sweden AB (Gothenburg, Sweden), Vitrolife Inc. (Denver,
Colorado). The group's operations is focused on three geographic areas.

· Europe/Middle East
· The Americas
· Rest of the World

Vitrolife's business concept is to develop, produce and sell advanced
products and systems for the preparation, cultivation, preservation and
support of cells, tissues and organs.